Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30620557 | 1.00 | KMT2A (0.43) | KMT2AOPRD1TLR2ALDH1A1EPHX2 | |
| SCHEMBL29101925 | 0.92 | KMT2A (0.47) | KMT2AOPRD1ALDH1A1EPHX2CASP3 | |
| SCHEMBL30918231 | 0.92 | KMT2A (0.47) | KMT2AOPRD1ALDH1A1EPHX2CASP3 | |
| SCHEMBL30712765 | 0.92 | KMT2A (0.47) | KMT2AOPRD1ALDH1A1EPHX2CASP3 | |
| SCHEMBL31089986 | 0.92 | KMT2A (0.47) | KMT2AOPRD1ALDH1A1EPHX2CASP3 | |
| SCHEMBL29101957 | 0.89 | KMT2A (0.47) | KMT2AOPRD1TLR2EPHX2CASP3 | |
| SCHEMBL29101955 | 0.88 | KMT2A (0.41) | KMT2AOPRD1TLR2ALDH1A1CASP3 | |
| SCHEMBL30620548 | 0.86 | KMT2A (0.47) | KMT2AOPRD1TLR2EPHX2CASP3 | |
| SCHEMBL30705439 | 0.85 | KMT2A (0.53) | KMT2AOPRD1ALDH1A1EPHX2CASP3 | |
| SCHEMBL30712763 | 0.85 | KMT2A (0.47) | KMT2AOPRD1ALDH1A1EPHX2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008102-A1 | LINKER FOR CONJUGATION | WUXI XDC (SHANGHAI) CO., LTD. (CN) | 2024-01-11 | — | — | WO | disclosed |